-
Most Recent
CLDN
5 Biotechnology Stocks to Buy Now
The grades of five biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
5 Biotechnology Stocks to Buy Now
The grades of five biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
5 Biotechnology Stocks to Buy Now
This week, five biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
Celladon Corp (CLDN) Shares Plummet Following Clinical Trial Failure
Celladon Corp shares were down 80% as of Monday afternoon following news of a failed clinical trial for a heart failure treatment.
6 Biotechnology Stocks to Buy Now
This week, six biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
8 Biotechnology Stocks to Buy Now
This week, eight biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
5 Biotechnology Stocks to Buy Now
This week, five biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
